Bond Celgen Corporation 3.9% ( US151020BB94 ) in USD
Issuer | Celgen Corporation |
Market price | ![]() |
Country | ![]() |
ISIN code |
![]() |
Interest rate | 3.9% per year ( payment 2 times a year) |
Maturity | 19/02/2028 |
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
Minimal amount | 2 000 USD |
Total amount | 1 500 000 000 USD |
Cusip | 151020BB9 |
Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) |
Moody's rating | N/A |
Next Coupon | 20/08/2025 ( In 47 days ) |
Detailed description |
Celgene Corporation was a biopharmaceutical company acquired by Bristol Myers Squibb in 2019, known for its development and commercialization of cancer therapies and other immunology treatments. The Bond issued by Celgen Corporation ( United States ) , in USD, with the ISIN code US151020BB94, pays a coupon of 3.9% per year. The coupons are paid 2 times per year and the Bond maturity is 19/02/2028 The Bond issued by Celgen Corporation ( United States ) , in USD, with the ISIN code US151020BB94, was rated A+ ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |